Clinical Trials Browser

Withdrawn × Triple Negative Breast Neoplasms × glembatumumab vedotin × Clear all

NCT03473691 2024-12-09

Breast50

Phase EARLY_PHASE1 Withdrawn

Triple Negative Breast Neoplasms

NCT03326258 2018-07-18

Glembatumumab Vedotin, Nivolumab, and Ipilimumab in Treating Patients With Advanced Metastatic Solid Tumors That Cannot Be Removed by Surgery

Phase 1/2 Withdrawn

BreastDermatologic

Uveal Melanoma, Breast Neoplasms, Melanoma, Neoplasm Metastasis, Triple Negative Breast Neoplasms